BioSig Technologies Competitors and Similar CompaniesClear all

BioSig Technologies's competitors and similar companies include Smith & Nephew, Intersect ENT, Impulse Dynamics and In'Tech Medical.

	BioSig Technologies BioSig Technologies is a medical device company developing a biomedical signal processing technology for the electrophysiology market.	Smith & Nephew Smith & Nephew is a medical technology company.	Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.	Impulse Dynamics Germany-based developer of an implantable device for treatment of chronic heart failure	In'Tech Medical In'Tech Medical is a company engaged in the manufacturing of orthopedic medical devices.
Founding Date	Founding Date 2009	Founding Date 1856	Founding Date 2003	Founding Date 1996	Founding Date 2000
Type	Type Public	Type Public	Type Subsidiary	Type Private	Type Private
Tags	Tags Healthcare medical devices medtech	Tags Healthcare healthtech medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech
Locations	Locations Westport, US HQ Los Angeles, US	Locations Watford, GB HQ Buenos Aires, AR Macquarie Park, AU Schwechat, AT Zaventem, BE São Paolo, BR Mississauga, CA see more	Locations Menlo Park, US HQ	Locations Stuttgart, DE HQ Frankfurt Am Main, DE Mount Laurel Township, US Pearl River, US Evesham, US	Locations Rang-du-Fliers, FR HQ La Farlède, FR Memphis, US
Employees	Employees 20	Employees 17,349	Employees 4337% increase	Employees 237	Employees 6813% decrease
Valuation ($)	Valuation ($) 16.3 m	Valuation ($) 13.4 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $200k (FY, 2025)	Revenue (est.) $6.2b (FY, 2025)	Revenue (est.) $106.7m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $1.4b (FY, 2025)	Cost of goods $30m (FY, 2021)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $4.8b (FY, 2025)	Gross profit $76.7m (FY, 2021)	Gross profit N/A	Gross profit N/A
Net income	Net income ($462.8m) (FY, 2025)	Net income $625m (FY, 2025)	Net income ($159.6m) (FY, 2021)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 31.2m	Total funding raised N/A	Total funding raised $ 102.9m	Total funding raised $ 215.3m	Total funding raised N/A